Loading clinical trials...
Loading clinical trials...
A 3-year, Open-label, Multi-center Extension Trial of Telbivudine Therapy for Patients Previously Treated in EFFORT Clinical Trial
Conditions
Interventions
telbivudine (ROADMAP)
Telbivudine (Standard of Care)
Locations
24
China
302 Military Hospital Of China
Beijing, Beijing Municipality, China
Beijing Ditan Hospita
Beijing, Beijing Municipality, China
Beijing Friendship Hospital Attached To The Capital Medical University
Beijing, Beijing Municipality, China
BeiJing YouAn Hospital ,Capital Medical University
Beijing, Beijing Municipality, China
Department of Infectious Disease, First Hospital of Peking University
Beijing, Beijing Municipality, China
People's Hospital Under Beijnig University
Beijing, Beijing Municipality, China
Start Date
August 1, 2011
Primary Completion Date
August 1, 2015
Completion Date
December 1, 2015
Last Updated
June 19, 2014
NCT04166266
NCT06550622
NCT05922306
NCT05870969
NCT04856085
NCT04780204
Lead Sponsor
Nanfang Hospital, Southern Medical University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions